B47. Asthma Epidemiology: Clinical and Pharmacological Determinants of Asthma Outcomes 2010
DOI: 10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3126
|View full text |Cite
|
Sign up to set email alerts
|

Cost Comparison Among Moderate Or Severe Persistent Asthma Patients With And Without Asthma Exacerbations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…This group of severe asthmatics, however, is responsible for a disproportionate share of the morbidity associated with the disease. The severe asthma group is responsible for most of the asthma-related healthcare burden, represented by the costs of hospitalizations, ER visits, physician office visits, and use of medications [3][4][5]. This increased burden of severe asthma reflects the inability of the existing treatment options to adequately control asthma in patients with severe disease.…”
Section: Introductionmentioning
confidence: 99%
“…This group of severe asthmatics, however, is responsible for a disproportionate share of the morbidity associated with the disease. The severe asthma group is responsible for most of the asthma-related healthcare burden, represented by the costs of hospitalizations, ER visits, physician office visits, and use of medications [3][4][5]. This increased burden of severe asthma reflects the inability of the existing treatment options to adequately control asthma in patients with severe disease.…”
Section: Introductionmentioning
confidence: 99%